Genital Hygiene Behaviors and Predicting Factors

October 16, 2023 updated by: Esra Çalışkan, Istanbul University - Cerrahpasa (IUC)

Genital Hygiene Behaviors and Predicting Factors in Women Living in A Country: The Sample of Turkey

The aim of this study was to determine the genital hygiene practices of women in different regions of Turkey and the factors influencing these practices. It is a descriptive, cross-sectional study. The study was conducted according to the STROBE checklist.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The aim of this study was to determine the genital hygiene practices of women in different regions of Turkey and the factors influencing these practices. It is a descriptive, cross-sectional study.

Data Collection Tools Data for the study was collected through the "Data Collection Form" and "Genital Hygiene Behaviors Inventory", created by the researchers by reviewing the literature (Karahan, 2017; Cankaya, 2013; Elzayat et al. 2017; Adam and Saadia, 2016; Akgul, 2019).

Data collection form: A survey consisting of 13 questions about the age of the women, the amount of water consumed daily, the number of urinations, the genital infection status, and sexuality.

Genital Hygiene Behaviors Inventory - GHBI: A scale, developed by Karahan (2017), and for which written permission for use was obtained, consisting of 23 items in total and 3 sub-dimensions: "genital hygiene behaviors", "menstrual habits" and "abnormal findings". Items 1-12 evaluate genital hygiene, items 13-20 evaluate menstrual hygiene, and items 21-23 evaluate the awareness of abnormal findings. Items 7, 14, 19, 20 and 23 of the scale are the reversed items and are reverse coded during the evaluation. A minimum total of 23 and a maximum total of 115 points can be obtained from the 5-point Likert-type scale, where "1" point means "I totally disagree" and "5" points means "I completely agree". Higher scale scores correspond to better genital hygiene behaviors. The study evaluating the development of the scale and its validity and reliability determined the Cronbach's Alpha coefficient as 0.80 (Karahan, 2017); our study's Cronbach's Alpha coefficient was 0.78.

Data Collection The prepared data collection form and the scale were transferred to the computer environment and delivered online to the women through the snowball sampling method. It took approximately 10 minutes for each participant to complete the data collection forms Data Analysis The data collected in the study was analyzed using the Statistical Package for the Social Sciences, version 25.0 (SPSS, v25.0) statistical analysis package program (IBM Company, Turkey). First the descriptive data of the study was analyzed. Mean, median, standard deviation, minimum and maximum values were calculated in the analysis of continuous data, and numbers and percentages were calculated in the analysis of categorical data. Next, non-parametric and parametric tests were used according to normality distributions. Pearson Chi-square test, Kruskal Wallis Test and Mann Whitney-U tests were used to analyze the data. A simple linear regression analysis model was used to determine the factors affecting genital hygiene behaviors. Statistical significance level was accepted as p<.05 at 95% confidence interval.

Study Type

Observational

Enrollment (Actual)

881

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

The population of the study consisted of all women throughout Turkey, while the sample consisted of women who met the inclusion criteria of the study.

The criteria for inclusion in the study are: (i) being able to read and understand Turkish, (ii) meeting the conditions for voluntary participation in the study. The sample consisted of 881 women reached online by the snowball sampling method

Description

Inclusion Criteria:

  • Agreeing to participate in the study,
  • To speak and understand Turkish,
  • women

Exclusion Criteria:

  • not being able to read and understand Turkish
  • dont want to participate the research

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Genital Hygiene Behavior Inventory (GHBI)
Time Frame: 1 times
Likert type inventory consisting of 27 questions evaluating genital hygiene behaviors.Inventory was applied to all pregnant women participating in the study at the beginning and at the end of the study.
1 times
Data collection form:
Time Frame: 1 times
This survey was created by the researchers according to the literature.6-9 The survey consisted of 13 questions about the sociodemographic features and the behaviors related genital tract infections.
1 times

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Istanbul University - Cerrahpasa (IUC)

Investigators

  • Study Director: Esra Çalışkan, Msc, Istanbul University - Cerrahpasa (IUC)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 7, 2022

Primary Completion (Actual)

November 12, 2022

Study Completion (Actual)

February 15, 2023

Study Registration Dates

First Submitted

October 16, 2023

First Submitted That Met QC Criteria

October 16, 2023

First Posted (Actual)

October 19, 2023

Study Record Updates

Last Update Posted (Actual)

October 19, 2023

Last Update Submitted That Met QC Criteria

October 16, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ECaliskan1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Research results will be shared

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Urinary Tract Infections

Clinical Trials on No intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe